This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
The Energy Breakthrough That Could Power the AI Revolution
General Fusion CEO Greg Twinney explains why fusion energy is gaining momentum, how it could power the AI boom, and what comes next for the industry.
U.S. Hits Brazil With Sweeping 25% Tariffs
The Trump administration has imposed a 25% tariff on most imports from Brazil, citing what it calls unfair trade practices under a Section 301 investigation.
Nvidia Doubles Down On Japan’s AI Future
Nvidia is expanding its push into Japan with a new artificial intelligence model designed to accelerate the development of “physical AI”.
Grocery Aisles Go Quiet As Shoppers Cut Back
America’s grocery carts are getting lighter as new data shows shoppers are buying fewer items per trip.
Warsh Defends Fed Independence Amid Trump Questions
Federal Reserve Chair Kevin Warsh faced pointed questions on Capitol Hill over his relationship with the Trump administration.
Social Security Reform Takes Center Stage
Social Security is back at the center of Washington's agenda as lawmakers weigh proposals aimed at strengthening the program's long-term finances.
